Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
L-glutamine
|
| gptkbp:age |
patients 5 years and older
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
none assigned
|
| gptkbp:chemicalClass |
amino acid transporter
|
| gptkbp:form |
oral powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
Endari
|
| gptkbp:indication |
reduce acute complications of sickle cell disease
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Emmaus_Medical
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain constipation headache cough chest pain pain in extremities |
| gptkbp:usedFor |
sickle cell disease
|
| gptkbp:bfsParent |
gptkb:Emmaus_Life_Sciences
|
| gptkbp:bfsLayer |
6
|